Advertisement

Picture EBD Group BIO-Europe Spring 2021 Digital 650x80
Organisation › Details

Confo Therapeutics N.V.

Confo Therapeutics is a VUB-VIB spin-off co-founded in 2015 by VIB and Capricorn Venture Partners with the support of MINTS, PMV, QBIC and V-Bio Ventures. The Company is building a portfolio of first-in-class programs based on its proprietary Confo® technology which makes use of antibody fragments or “Confobodies” to stabilize G-protein coupled receptors (GPCRs) in a particular conformation of interest as a superior starting point for drug discovery. GPCRs are attractive drug targets in the treatment of many different conditions, playing an essential part in numerous life processes and influencing diseases. In addition to developing its own pipeline, Confo Therapeutics is entering into revenue-generating drug discovery partnerships with select pharma companies, on GPCR targets which do not compete with its internal projects. The Company has ongoing collaborations with Lundbeck and Roche. *

 

Period Start 2015-06-01 established (s-off)
  Predecessor VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie)
Products Industry drug discovery
  Industry 2 GPCR inhibitor
Person Person Ververken, Cedric (Confo Therapeutics 201610– CEO before Ablynx)
     
Region Region Brussels
  Country Belgium
  Street 2 Pleinlaan
Building E, 7th Floor, Room E7.6
  City 1050 Brussels
    Address record changed: 2020-12-02
     
Basic data Employees B: 11 to 50 (2017-10-26)
     
    * Document for �About Section�: Confo Therapeutics N.V.. (1/3/19). "Press Release: Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology". Ghent.
     
   
Record changed: 2019-08-09

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Confo Therapeutics N.V.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80




» top